Clinical Trial Update: SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes [NA]

View source ↗

Summary

Clinical trial update on the use of SGLT2 inhibitors to study survival in lung cancer patients with diabetes; the trial status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• SGLT2 inhibitors (class)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Lung Cancer | NA | Status: NOT_YET_RECRUITING